13F HOLDINGS REPORT
Atlas Venture Life Science Advisors, LLC
Quarter ended Q3 2025 · Filed November 13, 2025 · Accession 0001104659-25-111321
Total Value
$752.6M
Positions
9
Other Managers
0
Confidential Omitted
No
Holdings (9)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Kymera Therapeutics, Inc. | KYMR | 4,896,462 | $277.1M | 36.82% |
| 2 | Disc Medicine, Inc. | IRON | 2,142,617 | $141.6M | 18.81% |
| 3 | Dyne Therapeutics, Inc. | DYN | 9,130,465 | $115.5M | 15.35% |
| 4 | Sionna Therapeutics, Inc. | SION | 3,615,527 | $106.3M | 14.13% |
| 5 | Korro Bio, Inc. | KRRO | 1,137,149 | $54.5M | 7.24% |
| 6 | Day One Biopharmaceuticals, Inc. | DAWN | 6,430,257 | $45.3M | 6.02% |
| 7 | Generation Bio, Co. | 37148K100 | 827,946 | $5.1M | 0.67% |
| 8 | Q32 Bio, Inc. | QTTB | 2,092,106 | $4.1M | 0.55% |
| 9 | ImageneBio, Inc. | IMA | 377,814 | $3.1M | 0.41% |